An Evidence-based Perspective of Coriolus Versicolor (Multicolored Polypore Mushroom) for Cancer Patients

[1]  Xiaoqiu Xiao,et al.  Immunomodulatory effects of polysaccharopeptide (PSP) in human PBMC through regulation of TRAF6/TLR immunosignal-transduction pathways , 2010, Immunopharmacology and immunotoxicology.

[2]  J. Slaton,et al.  Role for toll-like receptor 4 in TNF-alpha secretion by murine macrophages in response to polysaccharide Krestin, a Trametes versicolor mushroom extract. , 2010, Fitoterapia.

[3]  H. Baba,et al.  PSK may suppress CD57+ T cells to improve survival of advanced gastric cancer patients , 2010, International Journal of Clinical Oncology.

[4]  A. Tanaka,et al.  Effects of preoperative immunochemoradiotherapy and chemoradiotherapy on immune responses in patients with rectal adenocarcinoma. , 2010, Anticancer research.

[5]  G. C. Chan,et al.  The effects of β-glucan on human immune and cancer cells , 2009, Journal of Hematology & Oncology.

[6]  Masafumi Nakamura,et al.  A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model. , 2009, Anticancer research.

[7]  V. Wray,et al.  Production and structural analysis of the polysaccharide secreted by Trametes (Coriolus) versicolor ATCC 200801 , 2009, Applied Microbiology and Biotechnology.

[8]  A. Vickers,et al.  Evaluation of widely consumed botanicals as immunological adjuvants. , 2008, Vaccine.

[9]  Eunhye Kim,et al.  Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from Korea. , 2008, Journal of agricultural and food chemistry.

[10]  M. Mostarica‐Stojković,et al.  Anti-tumor effect of Coriolus versicolor methanol extract against mouse B16 melanoma cells: in vitro and in vivo study. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[11]  F. Garrido,et al.  The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis , 2008, BMC Cancer.

[12]  J. Wan,et al.  Polysaccharopeptide enhances the anticancer activity of doxorubicin and etoposide on human breast cancer cells ZR-75-30. , 2008, International journal of oncology.

[13]  D. Uemura,et al.  Biological activity, structural features, and synthetic studies of (-)-ternatin, a potent fat-accumulation inhibitor of 3T3-L1 adipocytes. , 2008, Chemistry, an Asian journal.

[14]  R. Katoh,et al.  Enhancement of antitumor effect of tegafur/uracil (UFT) plus leucovorin by combined treatment with protein-bound polysaccharide, PSK, in mouse models. , 2007, Cellular & molecular immunology.

[15]  G. Hedjaroude,et al.  Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). , 2007, International immunopharmacology.

[16]  R. Seviour,et al.  Medicinal importance of fungal -(1?3), (1?6)-glucans , 2007 .

[17]  Y. Kodera,et al.  Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer , 2007, Cancer Immunology, Immunotherapy.

[18]  Y. Ohashi,et al.  Adjuvant Immunochemotherapy with Protein-Bound Polysaccharide K for Colon Cancer in Relation to Oncogenic β-Catenin Activation , 2007, Diseases of the colon and rectum.

[19]  T. Hsieh,et al.  Bmc Complementary and Alternative Medicine Induction of Cell Cycle Changes and Modulation of Apoptogenic/anti-apoptotic and Extracellular Signaling Regulatory Protein Expression by Water Extracts of I'm-yunity™ (psp) , 2006 .

[20]  C. Schmidt.  Immune system's Toll-like receptors have good opportunity for cancer treatment. , 2006, Journal of the National Cancer Institute.

[21]  J. Yeung,et al.  Effects of polysaccharide peptide (PSP) from Coriolus versicolor on the pharmacokinetics of cyclophosphamide in the rat and cytotoxicity in HepG2 cells. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[22]  J. Yeung,et al.  Polysaccharide peptides from COV-1 strain of Coriolus versicolor induce hyperalgesia via inflammatory mediator release in the mouse. , 2006, Life sciences.

[23]  N. Rowan,et al.  Medicinal Mushrooms and Cancer Therapy: translating a traditional practice into Western medicine , 2006, Perspectives in biology and medicine.

[24]  I. Takeyoshi,et al.  Beneficial effects of protein-bound polysaccharide K plus tegafur/uracil in patients with stage II or III colorectal cancer: analysis of immunological parameters. , 2006, Oncology reports.

[25]  Y. Ohashi,et al.  Efficacy of adjuvant Immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials , 2006, Cancer Immunology, Immunotherapy.

[26]  B. Tóth,et al.  Lack of prevention of large intestinal cancer by VPS, an extract of Coriolus versicolor mushroom. , 2005, In vivo.

[27]  C. Hon,et al.  Molecular characterization of Coriolus versicolor PSP-induced apoptosis in human promyelotic leukemic HL-60 cells using cDNA microarray. , 2005, International journal of oncology.

[28]  A. Vickers,et al.  Rituximab therapy of lymphoma is enhanced by orally administered (1-->3),(1-->4)-D-beta-glucan. , 2005, Leukemia research.

[29]  J. Wan,et al.  The cell death process of the anticancer agent polysaccharide-peptide (PSP) in human promyelocytic leukemic HL-60 cells. , 2005, Oncology reports.

[30]  K. Leung,et al.  Differential anti-tumor activity of coriolus versicolor (Yunzhi) extract through p53- and/or Bcl-2-dependent apoptotic pathway in human breast cancer cells , 2005, Cancer biology & therapy.

[31]  E. Jiménez,et al.  Identification of the protein components of protein-bound polysaccharide (PSK) that interact with NKL cells , 2005, Cancer Immunology, Immunotherapy.

[32]  M. Schaller,et al.  Toll-like receptors as key mediators in innate antifungal immunity. , 2004, Medical mycology.

[33]  K. Fung,et al.  Differential effect of Coriolus versicolor (Yunzhi) extract on cytokine production by murine lymphocytes in vitro. , 2004, International immunopharmacology.

[34]  Jun Yan,et al.  Mechanism by Which Orally Administered β-1,3-Glucans Enhance the Tumoricidal Activity of Antitumor Monoclonal Antibodies in Murine Tumor Models1 , 2004, The Journal of Immunology.

[35]  D. Kasper,et al.  Polysaccharide Processing and Presentation by the MHCII Pathway , 2004, Cell.

[36]  T. Nakajima,et al.  Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study , 2004, British Journal of Cancer.

[37]  Y. Ohashi,et al.  Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer , 2004, International Journal of Colorectal Disease.

[38]  S. Takenoshita,et al.  Effect of PSK on the maturation of dendritic cells derived from human peripheral blood monocytes. , 2004, Immunology letters.

[39]  C. Lam,et al.  Immunomodulatory effects of yun zhi and danshen capsules in health subjects--a randomized, double-blind, placebo-controlled, crossover study. , 2004, International immunopharmacology.

[40]  J. Zjawiony.  Biologically active compounds from Aphyllophorales (polypore) fungi. , 2004, Journal of natural products.

[41]  Siamon Gordon,et al.  The Role of SIGNR1 and the β-Glucan Receptor (Dectin-1) in the Nonopsonic Recognition of Yeast by Specific Macrophages1 , 2004, The Journal of Immunology.

[42]  J. Monro.  Treatment of Cancer with Mushroom Products , 2003, Archives of environmental health.

[43]  M. Miyazaki,et al.  A randomized controlled trial of postoperative adjuvant immunochemotherapy for colorectal cancer with oral medicines. , 2003, International journal of oncology.

[44]  G. Ooi,et al.  Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. , 2003, Respiratory medicine.

[45]  Yusuf Chisti,et al.  Polysaccharopeptides of Coriolus versicolor: physiological activity, uses, and production. , 2003, Biotechnology advances.

[46]  Z. Darżynkiewicz,et al.  Effects of extracts of Coriolus versicolor (I'm-Yunity) on cell-cycle progression and expression of interleukins-1 beta,-6, and -8 in promyelocytic HL-60 leukemic cells and mitogenically stimulated and nonstimulated human lymphocytes. , 2002, Journal of alternative and complementary medicine.

[47]  A. Vickers,et al.  Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies , 2002, Cancer Immunology, Immunotherapy.

[48]  J. Mau,et al.  Antioxidant properties of several medicinal mushrooms. , 2002, Journal of agricultural and food chemistry.

[49]  A. Chow,et al.  Coriolus versicolor: A Medicinal Mushroom with Promising Immunotherapeutic Values , 2002, Journal of clinical pharmacology.

[50]  S. Kudo,et al.  Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker. , 2002, Oncology reports.

[51]  C. Hobbs.  Medicinal Mushrooms: An Exploration of Tradition, Healing, & Culture , 2002 .

[52]  M. Fukuzawa,et al.  Immunomodulatory Effects of Low Dose cis-Diaminedichloroplatinum (Cisplatin) Combined with UFT and PSK in Patients with Advanced Colorectal Cancer , 2002, Cancer investigation.

[53]  W. Abraham.  Bioactive sesquiterpenes produced by fungi: are they useful for humans as well? , 2001, Current medicinal chemistry.

[54]  V. Piironen,et al.  Contents of vitamins, mineral elements, and some phenolic compounds in cultivated mushrooms. , 2001, Journal of agricultural and food chemistry.

[55]  H. Iijima,et al.  Neonatal inoculation with the protein-bound polysaccharide PSK increases resistance of adult animals to challenge with syngeneic tumor cells and reduces azoxymethane-induced precancerous lesions in the colon. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[56]  F. Levi-Schaffer,et al.  Role of reactive oxygen species (ROS) in apoptosis induction , 2000, Apoptosis.

[57]  T. Toge,et al.  Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count. , 2000, Oncology reports.

[58]  P. Kidd.  The use of mushroom glucans and proteoglycans in cancer treatment. , 2000, Alternative medicine review : a journal of clinical therapeutic.

[59]  F. Garrido,et al.  Differential effect of protein-bound polysaccharide (PSK) on survival of experimental murine tumors. , 1999, Journal of experimental & clinical cancer research : CR.

[60]  T. T. Stevenson,et al.  A Novel Carbohydrate-Glycosphingolipid Interaction between a β-(1–3)-Glucan Immunomodulator, PGG-glucan, and Lactosylceramide of Human Leukocytes* , 1998, The Journal of Biological Chemistry.

[61]  J. Hamada,et al.  Polysaccharide K induces Mn superoxide dismutase (Mn-SOD) in tumor tissues and inhibits malignant progression of QR-32 tumor cells: possible roles of interferon α, tumor necrosis factor α and transforming growth factor β in Mn-SOD induction by polysaccharide K , 1998, Cancer Immunology, Immunotherapy.

[62]  H. Makuuchi,et al.  Immunotherapy and combined assay of serum levels of carcinoembryonic antigen and acute-phase reactants , 1998, Cancer Immunology, Immunotherapy.

[63]  H. Makuuchi,et al.  HLA-A2 Antigen status predicts metastasis and response to immunotherapy in gastric cancer , 1997, Cancer Immunology, Immunotherapy.

[64]  S. Takenoshita,et al.  Changes in serum soluble IL-2 receptors (sIL-2R) and immunosuppressive acidic protein (IAP) associated with chemotherapy for lung cancer. , 1997, Anticancer research.

[65]  W. Chan,et al.  Polysaccharopeptide from the mushroom Coriolus versicolor possesses analgesic activity but does not produce adverse effects on female reproductive or embryonic development in mice. , 1997, General pharmacology.

[66]  J. Horiguchi,et al.  HLA antigen as predictive index for the outcome of breast cancer patients with adjuvant immunochemotherapy with PSK. , 1997, Anticancer research.

[67]  Qing-Yao Yang.  Yun Zhi Polysaccharopeptide (PSP) and the General Aspects of Its Research , 1997 .

[68]  T. Ng,et al.  Polysaccharopeptide from Coriolus versicolor has potential for use against human immunodeficiency virus type 1 infection. , 1997, Life sciences.

[69]  R. Wang,et al.  Liver injury model induced in mice by a cellular immunologic mechanism--study for use in immunopharmacological evaluations. , 1997, Pharmacological research.

[70]  V. Ooi,et al.  Free radical scavenging activities of mushroom polysaccharide extracts. , 1997, Life sciences.

[71]  S. Matsumoto.  Effect of molsidomine on basal Ca2+ current in rat cardiac cells. , 1997, Life sciences.

[72]  D. Gridley,et al.  Immunotherapy with low-dose interleukin-2 and a polysaccharopeptide derived from Coriolus versicolor. , 1996, Cancer biotherapy & radiopharmaceuticals.

[73]  M. M. Yang,et al.  Antitumor effects of a refined polysaccharide peptide fraction isolated from Coriolus versicolor: in vitro and in vivo studies. , 1996, Research communications in molecular pathology and pharmacology.

[74]  V. Ooi,et al.  Induction in the mouse of gene expression of immunomodulating cytokines by mushroom polysaccharide-protein complexes. , 1996, Life sciences.

[75]  K. Sugimachi,et al.  Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC) of Japan. , 1996, European journal of cancer.

[76]  J. Horiguchi,et al.  Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer. , 1995, Anticancer research.

[77]  K. Isono,et al.  Immunotherapy for Esophageal Cancer: A Randomized Trial in Combination with Radiotherapy and Radiochemotherapy , 1995, American journal of clinical oncology.

[78]  H. Kobayashi,et al.  Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[79]  H. Saitǒ,et al.  Antitumor‐active substances from mushrooms , 1995 .

[80]  J. Sakamoto,et al.  Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer , 1994, The Lancet.

[81]  K. Saito,et al.  Suppression of in vivo tumor-induced angiogenesis by the protein-bound polysaccharide PSK. , 1994, In vivo.

[82]  N. Mitsuhashi,et al.  Effect of krestin (PSK) as adjuvant treatment on the prognosis after radical radiotherapy in patients with non-small cell lung cancer. , 1993, Anticancer research.

[83]  M. Fujii,et al.  PSK as a chemopreventive agent. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[84]  K. Sugimachi,et al.  Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer: 5‐year results from the nishi‐nippon group of the adjuvant chemoendocrine therapy for breast cancer organization , 1992, Cancer.

[85]  Y. Morishita,et al.  PSK (krestin) potentiates chemotherapeutic effects of tamoxifen on rat mammary carcinomas. , 1992, Anticancer research.

[86]  T. Leung,et al.  A clinical study of PSP on peripheral blood counts during chemotherapy , 1992 .

[87]  N. Ogawa,et al.  Randomized, controlled study on adjuvant immunochemotherapy with PSK® in curatively resected colorectal cancer , 1992 .

[88]  W. Breene.  Nutritional and Medicinal Value of Specialty Mushrooms. , 1990, Journal of food protection.

[89]  Hiroshi Yamamoto,et al.  Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer , 1990, Cancer Immunology, Immunotherapy.

[90]  S. Uchida,et al.  Effects of a protein-bound polysaccharide from a basidiomycetes against hepatocarcinogenesis induced by 3'-methyl-4-dimethylaminoazobenzene in rats. , 1990, Clinical therapeutics.

[91]  M. Takagi,et al.  [Effect of a protein-bound polysaccharide, PSK, on human hemopoietic progenitors]. , 1989, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society.

[92]  K. Sugimachi,et al.  Postoperative adjuvant immunochemotherapy with mitomycin C, futraful and PSK for gastric cancer. An analysis of data on 579 patients followed for five years , 1988, The Japanese journal of surgery.

[93]  T. Ebina,et al.  Antitumor Effector Mechanism at a Distant Site in the Double Grafted Tumor System of PSK, a Protein‐bound Polysaccharide Preparation , 1988, Japanese journal of cancer research : Gann.

[94]  M. Katano,et al.  [A suppressive effect of PSK, a protein-bound polysaccharide preparation, on tumor growth: a new effect of PSK on cell motility]. , 1987, Gan to kagaku ryoho. Cancer & chemotherapy.

[95]  T. Ando,et al.  Effect of PSK on cytotoxicity against sarcoma-180 in tumor-bearing mice. , 1987, Anticancer research.

[96]  T. Yoshikawa,et al.  Protection by BCG, levamisole, PS-K, OK-432, and vitamin E against carbon tetrachloride hepatotoxicity. , 1982, Hepato-gastroenterology.

[97]  M. Sakita,et al.  [Effect of PSK on DMH (dimethyl hydrazine) induction of cancer]. , 1982, Gan to kagaku ryoho. Cancer & chemotherapy.

[98]  K. Yamauchi,et al.  Chemoimmunotherapy with Krestin in acute leukemia. , 1981, The Tokai journal of experimental and clinical medicine.

[99]  T. Yoshikawa,et al.  Effect of Long-Term Administration of OK-432 (Picibanil), PS-K (Krestin) and Levamisole on Immune Responses in Aged Subjects Without Malignancy , 1979 .

[100]  T. Takeuchi,et al.  Coriolin, a new Basidiomycetes antibiotic. , 1969, The Journal of antibiotics.

[101]  C. Bridge,et al.  Trametes versicolor mushroom immune therapy in breast cancer. , 2008, Journal of the Society for Integrative Oncology.

[102]  A. Menderes.  Effects of protein-bound polysaccharide against some microorganisms (*) , 2008 .

[103]  Y. Ohashi,et al.  Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: Covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system , 2006, Surgery Today.

[104]  J. Drews,et al.  The effect of a protein-bound polysaccharide from coriolus versicolor on immunological parameters and experimental infections in mice , 2005, Infection.

[105]  C. Lam,et al.  Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. , 2005, The American journal of Chinese medicine.

[106]  Toru Nakamura,et al.  A randomized trial of chemoimmunotherapy of acute nonlymphocytic leukemia in adults using a protein-bound polysaccharide preparation , 2004, Cancer Immunology, Immunotherapy.

[107]  D. Mickey.  Combined therapeutic effects of an immunomodulator, PSK, and chemotherapy with carboquone on rat bladder carcinoma , 2004, Cancer Chemotherapy and Pharmacology.

[108]  H. Zhang,et al.  Protein-bound polysaccharide PSK inhibits tumor invasiveness by down-regulation of TGF-β1 and MMPs , 2004, Clinical & Experimental Metastasis.

[109]  J. Mau,et al.  Non-volatile components of several medicinal mushrooms , 2001 .

[110]  T. Hsieh,et al.  Cell growth and gene modulatory activities of Yunzhi (Windsor Wunxi) from mushroom Trametes versicolor in androgen-dependent and androgen-insensitive human prostate cancer cells. , 2001, International journal of oncology.

[111]  Y. Ohashi,et al.  Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer. , 1999 .

[112]  T. Mizuno.  The Extraction and Development of Antitumor-Active Polysaccharides from Medicinal Mushrooms in Japan (Review) , 1999 .

[113]  Laurent Meijer,et al.  Antitumor and Hypoglycemic Activities of Polysaccharides from the Sclerotia and Mycelia of Inonotus obliquus (Pers.: Fr.) Pil. (Aphyllophoromycetideae) , 1999 .

[114]  Z. Qian,et al.  Involvement of interleukin-2 in analgesia produced by Coriolus versicolor polysaccharide peptides. , 1998, Zhongguo yao li xue bao = Acta pharmacologica Sinica.

[115]  T. Ng.  A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). , 1998, General pharmacology.

[116]  Z. Qian,et al.  Polysaccharide peptide (PSP) restores immunosuppression induced by cyclophosphamide in rats. , 1997, The American journal of Chinese medicine.

[117]  James N. BeMiller,et al.  (1→3)-β-d-Glucans as biological response modifiers: a review of structure-functional activity relationships , 1995 .

[118]  K. Isono,et al.  Possible predictive markers of immunotherapy in esophageal cancer: retrospective analysis of a randomized study. The Cooperative Study Group for Esophageal Cancer in Japan. , 1995, Cancer investigation.

[119]  M. Ghoneum,et al.  Immunomodulatory and anticancer effects of active hemicellulose compound (AHCC) , 1995 .

[120]  Y. Niitsu,et al.  Improved recovery of myelosuppression following chemotherapy in mice by combined administration of PSK and various cytokines. , 1994, Acta haematologica.

[121]  K. Saigenji,et al.  Enhancement of anti-cancer activity of cisdiaminedichloroplatinum by the protein-bound polysaccharide of Coriolus versicolor QUEL (PS-K) in vitro. , 1994, Cancer biotherapy.

[122]  Z. Chen,et al.  The anti-tumor effect of a small polypeptide from Coriolus versicolor (SPCV). , 1992, The American journal of Chinese medicine.

[123]  H. Iijima,et al.  Enhancement of effector cell activities in mice bearing syngeneic plasmacytoma X5563 by a biological response modifier, PSK. , 1992, Journal of clinical & laboratory immunology.

[124]  T. Shiraishi,et al.  Immunomodulation by orally administered protein-bound polysaccharide PSK in patients with gastrointestinal cancer , 1992, Biotherapy.

[125]  C. Nathan,et al.  Role of nitric oxide synthesis in macrophage antimicrobial activity. , 1991, Current opinion in immunology.

[126]  H. Sakagami,et al.  Induction of immunopotentiation activity by a protein-bound polysaccharide, PSK (review). , 1991, Anticancer research.

[127]  K. Kawa,et al.  Effects of biological response modifiers on childhood ALL being in remission after chemotherapy. , 1991, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[128]  Y. Nishiwaki,et al.  [A randomized controlled study of PSK combined immuno-chemotherapy for adenocarcinoma of the lung. The Advanced Lung Cancer Immuno-chemotherapy Study Group]. , 1990, Gan to kagaku ryoho. Cancer & chemotherapy.

[129]  H. Sakagami,et al.  Stimulation of interferon-gamma-induced human myelogenous leukemic cell differentiation by high molecular weight PSK subfraction. , 1990, Anticancer research.

[130]  T. Andoh,et al.  Fate and distribution of an antitumor protein-bound polysaccharide PSK (Krestin). , 1988, International journal of immunopharmacology.

[131]  M. Kondo.  CHAPTER 36 – EVALUATION OF AN ANTICANCER ACTIVITY OF A PROTEIN-BOUND POLYSACCHARIDE PS-K (KRESTIN) , 1985 .